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Abstract
Adherence to antiretroviral therapy is essential for maximising individual treatment outcomes and preventing the
development of drug resistance. It is, however, frequently compromised due to predictable, but adverse, scenarios
in the countries most severely affected by HIV/AIDS. This paper looks at lessons from three specific crises in south-
ern Africa: the 2008 floods in Mozambique, the ongoing political and economic crisis in Zimbabwe, and the 2007
public sector strike in South Africa. It considers how these crises impacted on the delivery of antiretroviral therapy
and looks at some of the strategies employed to mitigate any adverse effects. Based on this it makes recommen-
dations for keeping patients on treatment and limiting the development of drug resistance where treatment
interruptions are inevitable.
Review
Antiretroviral therapy (ART) adherence is compromised
under some situations in countries most heavily affected
by HIV/AIDS. A frequently cited meta-analysis affirmed
that patients in sub-Saharan Africa (sSA) record adher-
ence levels as good as those documented in the rich
world [1]. However, unfavourable contexts limit an indi-
vidual’s control over their own treatment.
Many early ART programmes which were the subject
of adherence studies in sSA captured a set of circum-
stances that cannot consistently be maintained in the
longer-term as treatment is scaled up. In particular,
inconsistent drug supplies have been shown to be an
important factor influencing adherence [see for example
[2-5]]. Both direct and indirect costs, a function of the
broader socioeconomic environment, also feature promi-
nently in relevant research [see for example [6-10]].
Any threats to ART adherence need to be taken ser-
iously if we are to optimise treatment outcomes for indi-
viduals. Robust evidence exists on the effect of
adherence on viral load [11-15], the immune system
[16-18], and clinical prognosis [16,19-23]. Most impor-
tantly perhaps, the increased risks of illness and death
amongst those that are poorly adherent are undeniable.
A recent study in South Africa concluded those patients
claiming less than 80% of their prescription refills were
over three times more likely to die than those claiming
more than 80% [21].
The development of drug resistance due to poor
adherence goes beyond the individual level. It becomes
a public health issue when drug resistant viral strains
are transmitted and this has been a major concern
amongst governments and health agencies. As treatment
was introduced in sSA, we were warned of a situation of
‘antiretroviral anarchy’ where the rapid emergence and
transmission of resistant viral strains would ultimately
limit treatment options [24]. Fortunately, transmitted
resistance in countries in sSA currently scaling up ART
programmes is still less than 5%, but needs to be moni-
tored closely [25]; increasing levels of resistance are
inevitable as treatment coverage expands. With non-
nucleoside reverse transcriptase inhibitor (NNRTI)-regi-
mens in particular (used most commonly in sSA), drug
resistance can develop after unplanned treatment inter-
ruptions of just a few days [26,27].
This article looks at ART adherence concerns arising
from three specific crises in the southern African region,
based on a literature review of reports and papers in the
public domain. It considers the impact of these crises
on adherence and explores strategies to try and keep
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to how ART interruptions arising from various scenarios
might be avoided and managed in future.
What types of situations compromise ART adherence
and how does this happen?
There are a huge range of different crises that can
potentially undermine ART treatment in southern Africa
and the broader region. These crises are of different nat-
ures, various durations (short term vs long term) and
vary in geographical extent (localised vs widespread).
They also manifest in different ways. This paper looks at
problems with health system functioning and ART
delivery during: 1) the 2008 floods in Mozambique,
2) the ongoing political and economic crisis in Zimbabwe,
and 3) the 2007 public sector strike in South Africa (see
Table 1). While each crisis is irrefutably unique in many
ways, we have used some of the obviously classifiable
features to frame the recommendations.
In the case of natural disasters (and particularly
floods), health concerns are often dominated by sanitary
problems and overcrowding in temporary camps, which
increase the risks of diarrhoeal diseases, cholera,
measles, and malaria [28]. In Mozambique reports sug-
gested that 72 people died of cholera and an equal num-
ber of other waterborne diseases, a number far greater
than the dozen or so that died as a result of rising flood
waters [29]. The immediate need to intervene with safe
access to clean water meant that other health problems
were eclipsed. Some longer term risks were however
identified, including: 1) poor access to food supplies,
potentially resulting in malnutrition, and 2) poor access
to health care, potentially resulting in worse maternal
and child health outcomes and inadequate management
of both acute and chronic diseases [30].
Situations that results in the displacement of large
numbers of people means those on ART may not be
able to access the medication they require. In Mozambi-
que, fleeting mention was made in a few reports of the
poor access to health facilities in resettlement areas, and
the fact that health posts (providing very basic services)
in these camps were slow to open due to a lack of drugs
[31,32]. Medecins Sans Frontiers reported in late
January 2008 that 60 patients in Mutarara (Tete pro-
vince) on HIV and TB treatment were missing and had
not come to the hospital to collect their monthly medi-
cation [33]. In this instance teams were sent out to find
them, but public health services do not generally have
the capacity to respond in this way.
Political and economic failure, which has widespread
implications for the health system, is harder to manage
and control for. Health care provision can become more
difficult due to the lack of drugs and medical supplies,
as well as insufficient numbers of health workers. In
Zimbabwe this resulted in the closure of some of the
largest hospitals in late 2008 [34]. Even where drugs
were free and health services available, patients
struggled to access them due to obstacles such as high
fuel and transport costs [35]. Under such circumstances
patients can’t afford all the basic necessities and are
forced to migrate, with deleterious consequences for
treatment.
How do health workers and ART patients respond to
such a chaotic situation and are these responses appro-
priate? In Zimbabwe there were reports of ART patients
missing drug doses, sharing drugs, selling their drugs
and changing regimens to try and cope with inadequate
drug supplies and poor economic circumstances, so
fuelling concerns of a drug-resistant HIV epidemic
[34,36,37]. On a more positive note, aid agencies and
donors were aware of the need to keep patients on
treatment and played an important role in ensuring the
provision of drug supplies for the ART programme.
The category of health system or service failure is all
encompassing as it can manifest in many ways, with
common examples including health worker strikes or
drug stock-outs. Such problems are often symptomatic of
broader political and/or economic collapse, although
here we concern ourselves primarily with shorter term
failures that are more confined to the health sector.
These generally result in patients not accessing necessary
health services for a limited period of time, as was the
case during the month-long South African public sector
strike in 2007. In this instance there were mixed reports
over the extent of the disruption, but a significant num-
ber of patients with HIV/AIDS and TB could not obtain
their treatment because of clinic closures [38,39].
Table 1 Three crises in southern Africa that have impacted on ART adherence
Nature of crisis Case study Major effect of crisis Duration of crisis Extent of crisis
1. Natural disasters 2008 floods in
Mozambique
Migration, damage to health
system infrastructure
Short to medium term Localised
2. Political and
economic failure
Ongoing situation in
Zimbabwe
Poverty, migration, health
system collapse
Long term Widespread
3. Health service or
system failure
2007 public sector
strike in South Africa
Poor access to health services Short term (but similar nature
crises can be longer term)
Widespread (but similar nature
crises can be localised)
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term, patients with buffer drug stocks would have possi-
bly been able to weather the crisis with little disruption
to treatment. However, in most cases patients only
obtain their drugs on a month by month basis and so
would have had little reserve. The Southern African
HIV Clinicians Society took the initiative of issuing a
press statement on how treatment interruptions should
be dealt with. This essentially advised patients to seek
help from other sources (either private pharmacies or
another hospital/clinic) and to stop all drugs simulta-
neously if need be, without decreasing the dose to make
treatment last longer [40]. Unfortunately, due to its late
release in media that few have access to and because it
was written in English, it is unlikely that this informa-
tion would have reached many of the ART patients who
needed it.
What strategies should be considered to keep ART
patients adherent on treatment?
The two key messages from this review are: 1) we need
to plan for and manage various crises impacting on
ART delivery; and 2) there are a number of strategies
that have been employed and should be evaluated.
Unfortunately, most of what has been tried to date has
been ‘too little, too late’ and there has been almost no
indication as to its effectiveness. Nonetheless, there are
conclusions and recommendations arising from the
review that provide a starting point.
Management strategies will vary according to the
duration of the crisis. Many shorter term crises like
those reviewed in this paper can be anticipated, indicat-
ing a need for sound planning and preparedness.
Patients could be given extra drug supplies to tide them
over a potentially difficult time. Anecdotal evidence sug-
gests that this strategy is used to help patients cope with
short periods of planned migration. It does, however,
come with the concern that relaxing controls on ART
m i g h tr e s u l ti nd r u g sb e i n gs h a r e do rs o l do nt h eb l a c k
market. It therefore has to be managed carefully.
Longer term crises, in contrast, cannot be planned for
so easily because of the chronic erosion to the health
system and the time taken to potentially restore services.
In these cases, close monitoring and proactive manage-
ment is needed to alleviate the effects of the crisis on
patient treatment, care and support. Health information
systems are central; needing to be sensitive enough to
alert managers to change (such as when fewer patients
start presenting for follow up or drug shortages are
imminent) and detailed enough to give a fairly complete
picture of what is happening. Our observation that
so little information exists on the impact of crises on
ART programmes, is testament to how poor such sys-
tems currently are. It is therefore no surprise that
management of disruptions to ART delivery is largely
ineffective. Looking beyond the crisis itself, a carefully
designed recovery plan will assist in restoring health sys-
tem functioning as quickly as possible.
Just as shorter term crises will be easier to weather
than longer term crisis, so too will localised disruptions
compared to widespread upheaval. Careful management
and some reorganisation of services may suffice with
localised disruptions. There was some evidence of this
happening in Mozambique, where new health posts
were set up and community workers used to search for
patients [31]. Such strategies do, however, have to be
implemented quickly and efficiently if they are to ensure
patient adherence to medication. The use of mobile
phones to keep contact with patients could be explored.
Widespread upheaval on the other hand, requires an
increased involvement and co-ordination of health sec-
tor partners, be they private, donor, NGO or faith
based. There were indications from Zimbabwe that such
partners played an important role in ensuring the conti-
nuation of ART drug supplies, despite operating in a
hostile environment where drug delivery and distribu-
tion were problematic [34]. In South Africa private
health care providers took care of many Intensive Care
Unit (ICU) patients during the strike [41]. In a country
like this, where the private health sector is large, there is
scope for exploring partnerships that could benefit a
wider range of patients in times of crisis.
Crises that are both widespread and longer term, like
that in Zimbabwe, often require a particularly holistic
approach to support patients on ART. This is because
the socio-economic circumstances of households
become compromised, meaning that simply ensuring
ongoing service delivery is not sufficient to maintain
ART adherence. In such cases extra assistance may be
required from a range of partners to manage the indir-
ect costs of seeking care, such as transport costs, and to
avoid a situation where people are having to trade-off
basic necessities.
F o ra l lt y p e so fc r i s i s ,w h e t h e rl o n go rs h o r tt e r m ,
widespread or localised, patient information systems
which facilitate tracking and enable patients to collect
their drugs from multiple locations would help tremen-
dously. This is because migration is often a common
outcome of a crisis. Even in South Africa, where patients
did not migrate during the strike, they were advised to
try and source their medication from other health facil-
ities or private pharmacies [40]. However, patients do
not carry any record of their medication on them and
so were told to take their pills along instead for the doc-
tor or pharmacist to identify, which obviously is not
ideal.
Lastly, the impact of deficient ART adherence during
crisis situations could be lessened through attention to
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worker training. If adherence counselling includes dis-
cussion on what to do in case of being unable to access
drugs, then it should be possible to avoid some of the
inappropriate coping strategies (such as sharing drugs or
reducing drug doses) reported in Zimbabwe. Clinicians
properly trained in managing treatment interruptions
could stagger the time at which different drug classes
are stopped during drug stock-outs to avoid the devel-
opment of NNRTI resistance in particular. Issuing such
guidance during a crisis, as was done in South Africa
[40], might supplement such measures but is unlikely to
be effective on its own.
Who takes responsibility?
There is no doubt that widespread, long term crises,
particularly those involving state failure and political
violence (such as in Zimbabwe), are the greatest threat
to ART adherence. In such situations there is an urgent
need to consider the question of responsibility. If gov-
ernment failure is making it difficult for people to
obtain the treatment they need and NGOs within the
country are struggling to operate in a hostile environ-
ment, should there not be some international responsi-
bility for people living with HIV/AIDS?
In addressing the situation of people living with AIDS
in Zimbabwe, there is scope to consider how the emer-
ging ‘Responsibility to Protect’ (RtoP) doctrine could be
applied [42]. The RtoP considers that ‘sovereign states
bear the responsibility to protect their citizens from
avoidable catastrophe, but that when they are unwilling
or unable to do so, that responsibility must be borne by
the broader community’[43]. It therefore sets new
norms for international security and human rights.
In the case of Zimbabwe, many patients on ART
struggled to access their treatment not only within the
country’s borders, but because they were forced to
migrate to neighbouring countries, especially South
Africa. Undocumented migrants in South Africa have a
constitutional right to access ART, but many remain
unable to do so [44]. Furthermore, one can argue that
these ‘migrants’ are in fact refugees, in which case the
role of the United Nations High Commissioner for
Refugees (UNHCR) in supporting access and adherence
to ART comes into question. The UNHCR has pledged
to keep HIV/AIDS as priority [45], however it is unclear
what is being done in this regard.
Conclusions
In conclusion, ART programmes in sSA will continue to
be challenged by a range of different crises. What we
have seen to date is that the need to prioritise often
results in immediate concerns arising from such crises
eclipsing those with longer-term consequences. HIV/
AIDS is by nature a long-term disease and failure to main-
tain treatment coverage and adherence will not immedi-
ately result in large numbers of deaths. Unfortunately this
does not mean that the consequences will be less severe -
only that they will play out for years to come. Responding
strategically to the various threats posed by a crisis calls
for careful consideration and co-ordination, rather than a
knee-jerk response. Ultimately, how we plan for and man-
age such crises could strongly influence treatment
outcomes in the years and decades to come.
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